These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7252521)

  • 41. Mechanism of action of gallamine.
    Galindo A; Kelly PJ
    Anesth Analg; 1980 Jul; 59(7):484-7. PubMed ID: 7190784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors.
    Oda K; Lambert EH; Lennon VA; Palmer AC
    Muscle Nerve; 1984; 7(9):705-16. PubMed ID: 6543919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor.
    Uchitel O; Engel AG; Walls TJ; Nagel A; Atassi MZ; Bril V
    Muscle Nerve; 1993 Dec; 16(12):1293-301. PubMed ID: 8232384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The action of chlorpromazine at an isolated cholinergic synapse.
    Argov Z; Yaari Y
    Brain Res; 1979 Mar; 164():227-36. PubMed ID: 218686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology.
    Tiedt TN; Albuquerque EX; Hudson CS; Rash JE
    J Pharmacol Exp Ther; 1978 May; 205(2):326-39. PubMed ID: 205647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of the action of hyperpolarization and ethanol on frog end-plate currents at different cholinoceptor densities].
    Giniatullin RA; Khazipov RN; Khamitov KhS
    Neirofiziologiia; 1988; 20(1):128-30. PubMed ID: 3380206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease.
    Sine SM
    Physiol Rev; 2012 Jul; 92(3):1189-234. PubMed ID: 22811427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
    Takamori M; Sakato S; Okumura S
    J Neurol Sci; 1984; 66(2-3):245-53. PubMed ID: 6099402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acetylcholine-induced ionic channels in rat skeletal muscle.
    Sakmann B
    Fed Proc; 1978 Oct; 37(12):2654-9. PubMed ID: 212327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrastructural studies on the acetylcholine receptor at motor end plates of normal and pathologic muscles.
    Porter CW; Barnard EA
    Ann N Y Acad Sci; 1976; 274():85-107. PubMed ID: 786117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.
    Niks EH; Kuks JB; Wokke JH; Veldman H; Bakker E; Verschuuren JJ; Plomp JJ
    Muscle Nerve; 2010 Aug; 42(2):283-8. PubMed ID: 20544919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential effects of perhydrohistrionicotoxin on neurally and iontophoretically evoked endplate currents.
    Albuquerque EX; Gage PW
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1596-9. PubMed ID: 206910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic stabilization of acetylcholine receptors in vertebrate neuromuscular junction by muscle activity.
    Rotzler S; Brenner HR
    J Cell Biol; 1990 Aug; 111(2):655-61. PubMed ID: 2380246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytoplasmic actin in postsynaptic structures at the neuromuscular junction.
    Hall ZW; Lubit BW; Schwartz JH
    J Cell Biol; 1981 Sep; 90(3):789-92. PubMed ID: 7026578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acetylcholine receptor protein. Neuromuscular transmission in immunized rabbits.
    Elmqvist D; Mattsson C; Heilbronn E; Lundh H; Libelius R
    Arch Neurol; 1977 Jan; 34(1):7-11. PubMed ID: 188405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
    Engel AG; Lambert EH; Gomez MR
    Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neostigmine-induced alterations at the mammalian neuromuscular junction. II. Ultrastructure.
    Hudson CS; Rash JE; Tiedt TN; Albuquerque EX
    J Pharmacol Exp Ther; 1978 May; 205(2):340-56. PubMed ID: 641832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Control of end-plate channel properties by neurotrophic effects and by muscle activity in rat.
    Brenner HR; Lømo T; Williamson R
    J Physiol; 1987 Jul; 388():367-81. PubMed ID: 2443692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.